B671 PRIA Fee Category
PRIA 3 Fee Determination Decision Tree:
Biochemical or Microbial Biopesticide Active Ingredient - New Product Registration
Below is the fee for your selected Fee Category for Fiscal Years 2016/2017
|Action Code||Description||FY16/17 Fee||Decision Time (months)|
|B671||New product; unregistered source of active ingredient(s); requires a petition to amend an established tolerance or tolerance exemption; requires: 1) submission of product specific data; or 2) citation of previously reviewed and accepted data; or 3) submission or citation of data generated at government expense; or 4) submission or citation of a scientifically-sound rationale based on publicly available literature or other relevant information that addresses the data requirement; or 5) submission of a request for a data requirement to be waived supported by a scientifically-sound rationale explaining why the data requirement does not apply. (2)||$ 12,764||17|
Do you plan to request either of the following types of waivers?
|50% waiver||You pay ---->>>>>||$ 6,382|
|75% waiver||You pay ---->>>>>||$ 3,191|
To pay the fee shown above, go to Paying PRIA Application Fees web page and follow the instructions.
|Action Code Interpretation|
An application for registration of a microbial or biochemical pesticide product that is not substantially similar or identical in its uses and/or formulation to products that are currently registered. These applications require product specific chemistry data, acute toxicity data and other Tier I mammalian and non-target toxicity data as determined by the general use patterns for the product. When public health pests are claimed, efficacy (product performance) data for the product must be submitted. This category includes products containing an active ingredient(s) that requires a change in, or establishment of, a tolerance or tolerance exemption, and in those situations there must be a petition to establish or amend an existing tolerance or tolerance exemption for the active ingredient.
All of the inerts used in the product must be either approved or pending with the Agency for the applicable uses.
An application for a new end-use product using a source of active ingredient that is not yet registered but has an application pending with the Agency for review, will be considered an application for a new product with an unregistered source of an active ingredient.